We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Sysmex to Distribute Affymetrix’s Diagnostic Arrays

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Sysmex to Distribute Affymetrix’s Diagnostic Arrays"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
Affymetrix has hired Japanese lab diagnostics company Sysmex to sell its GeneChip diagnostic arrays and instruments in Japan, and has enabled the company to develop and market its own in vitro diagnostics based on the GeneChip platform.
The deal gives Sysmex exclusive rights to distribute the diagnostic arrays and instruments in Japan, and could enable it to distribute the products to other countries in Southeast Asia.
Another part of the agreement gives Sysmex non-exclusive rights to use the GeneChip to develop and market its in vitro tests worldwide.
The company currently has tests in the areas of urinalysis, immunochemistry, hematology, and hemostasis, and is now marketing a test to detect lymph node metastases in breast cancer patients.
Financial terms of the agreements were not released.